Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Grant Pickering currently holds 28,000 shares of Athira Pharma, Inc. (ATHA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Grant Pickering has been a net seller of ATHA stock. They have purchased $60.4K and sold $25.5M worth of shares.
Grant Pickering's most recent insider trade was on Apr 9, 2026, when they sold 28,000 shares at $0.00 per share.
Grant Pickering serves as Executive at Athira Pharma, Inc. (ATHA). They have executed 217 insider transactions totaling $25.5M over their tenure at the company.
Grant Pickering holds the position of Executive at Athira Pharma, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Grant Pickering has shown a selling trading pattern, with $60.4K in total purchases and $25.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Grant Pickering was on Sep 3, 2024, when they sold $1.5M worth of PCVX shares. This transaction involved 13,669 shares at $110.15 per share.
Grant Pickering currently owns 28,000 shares of Athira Pharma, Inc. (ATHA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Grant Pickering's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Grant Pickering has 217 Form 4 filings on record as an insider at Athira Pharma, Inc..
Set alerts for Grant Pickering and 40,000+ other insiders.